- Home
- / Oncosil Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Oncosil Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-04
Market Capitalization
$53 M
2024-10-04
Revenue
$1.2 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 213.0K | 232.0K | 368.0K | 517.0K | 1.2M | |||
| Cost of goods sold | 961.0K | 845.0K | 1.4M | 1.5M | 2.2M | |||
| Gross profit | 4.4M | 3.6M | 2.9M | 483.0K | 219.0K | 55.0K | 100.0K | (683.0K) |
| Gross profit margin, % | 226.8% | 94.4% | 14.9% | 19.3% | -58.3% | |||
| Operating expense total | 13.0M | 12.4M | 7.1M | 10.7M | 10.7M | 11.3M | 12.0M | 14.4M |
| Depreciation and amortization | 40.0K | 39.0K | 149.0K | 185.0K | 127.0K | 176.0K | 44.0K | 36.0K |
| EBITDA | (8.6M) | (8.7M) | (4.2M) | (10.2M) | (10.5M) | (11.3M) | (11.9M) | (15.1M) |
| EBITDA margin, % | -4793.9% | -4504.7% | -3064.7% | -2309.7% | -1285.5% | |||
| EBIT | (8.6M) | (8.8M) | (4.4M) | (10.4M) | (10.6M) | (11.5M) | (12.0M) | (15.1M) |
| EBIT margin, % | -4880.8% | -4559.5% | -3112.5% | -2318.2% | -1288.6% | |||
| Interest income | 145.0K | 204.0K | 105.0K | 82.0K | 10.0K | 63.0K | 67.0K | 91.0K |
| Interest expense | 11.0K | 16.0K | 20.0K | 11.0K | 4.0K | 1.0K | ||
| Pre tax profit | (8.5M) | (8.6M) | (4.3M) | (10.4M) | (10.7M) | (11.3M) | (11.9M) | (15.1M) |
| Net Income | (8.5M) | (8.6M) | (4.3M) | (10.4M) | (10.7M) | (11.3M) | (11.9M) | (15.1M) |